QuickVue Influenza A+B Clinical Field Trial

Comparison of Swab Types for Specimen Collection

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00491283

Enrollment

Unknown

Registered

2007-06-26

Start date

2006-07-31

Completion date

2006-08-31

Last updated

2008-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza

Brief summary

A comparative study of different swab types used for collection of specimens for rapid inluenza testing

Interventions

DEVICESwab Specimen Collection (QuickVue)

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

SINGLE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

Subjects must have: * Fever (\>38°C) (at time of visit or within the previous 48 hrs by history) and at least two of the following symptoms: * Chills/sweats * Cough * Dyspnea (labored, difficult breathing) * Fatigue * Headache * Myalgia (deep muscle aches) * Nasal congestion * Runny nose * Sore throat

Exclusion criteria

* Patients who are undergoing treatment with antivirals, now or within the last 7 days cannot be included in this study.

Design outcomes

Primary

Measure	Time frame
Sensitivity and Specificity	five months

Secondary

Measure	Time frame
Sensitivity and Specificity	Positive and Negative Predictive Values

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026